Your browser doesn't support javascript.
loading
Clinical versus biomarker-based diagnosis of neurocognitive disorders.
Höglinger, Günter U; Boxer, Adam L; Lang, Anthony E.
Affiliation
  • Höglinger GU; Department of Neurology, Ludwig-Maximilians-Universität Hospital, Ludwig-Maximilians-Universität, 81377 Munich, Germany; German Center for Neurodegenerative Diseases, Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany. Electronic address: guenter.hoeglinger@med.uni-muenchen.de.
  • Boxer AL; Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.
  • Lang AE; University Health Network's Krembil Brain Institute, Edmond J Safra Program in Parkinson's Disease and the Rossy PSP Centre, Toronto Western Hospital, Toronto, ON, Canada.
Lancet Neurol ; 23(8): 765-766, 2024 Aug.
Article in En | MEDLINE | ID: mdl-39030034
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers / Neurocognitive Disorders Limits: Humans Language: En Journal: Lancet Neurol Journal subject: NEUROLOGIA Year: 2024 Document type: Article Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers / Neurocognitive Disorders Limits: Humans Language: En Journal: Lancet Neurol Journal subject: NEUROLOGIA Year: 2024 Document type: Article Country of publication: Reino Unido